• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢组学全基因组关联研究优先考虑多发性硬化症的潜在因果循环代谢物。

A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis.

机构信息

Lower Merion High School, Ardmore, PA, USA; Department of Genetics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, USA.

Department of Genetics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, USA.

出版信息

J Neuroimmunol. 2023 Jun 15;379:578105. doi: 10.1016/j.jneuroim.2023.578105. Epub 2023 May 11.

DOI:10.1016/j.jneuroim.2023.578105
PMID:37207441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10237183/
Abstract

To prioritize circulating metabolites that likely play causal roles in the pathogenesis of multiple sclerosis (MS). Two-sample Mendelian randomization analysis was performed to estimate the causal effects of 571 circulating metabolites on the risk of MS. Genetic instruments for circulating metabolites were obtained from three previous genome-wide association studies (GWAS) of the blood metabolome (N = 7824; 24,925; and 115,078; respectively), while genetic associations with MS were from a large GWAS by the International Multiple Sclerosis Genetics Consortium (14,802 cases and 26,703 control). The primary analysis was performed with the multiplicative random-effect inverse variance-weighted method, while multiple sensitivity analyses were conducted with the weighted median, weighted mode, MR-Egger, and MR-PRESSO. A total of 29 metabolites had suggestive evidence of causal associations with MS. Genetically instrumented levels of serine (OR = 1.56, 95% CI = 1.25-1.95), lysine (OR = 1.18, 95% CI = 1.01-1.38), acetone (OR = 2.45, 95% CI = 1.02-5.90), and acetoacetate (OR = 2.47, 95% CI = 1.14-5.34) were associated with a higher MS risk. Total cholesterol and phospholipids in large very-low-density lipoprotein were associated with a lower MS risk (OR = 0.83, 95% CI = 0.69-1.00; OR = 0.80, 95% CI = 0.68-0.95), but risk-increasing associations (OR = 1.20, 95% CI = 1.04-1.40; OR = 1.13, 95% CI = 1.00-1.28) were observed for the same two lipids in very large high-density lipoprotein. Our metabolome-wide Mendelian randomization study prioritized a list of circulating metabolites, such as serine, lysine, acetone, acetoacetate, and lipids, that likely have causal associations with MS.

摘要

为了确定在多发性硬化症(MS)发病机制中可能起因果作用的循环代谢物。进行了两样本孟德尔随机化分析,以估计 571 种循环代谢物对 MS 风险的因果影响。循环代谢物的遗传工具来自三项先前的血液代谢组全基因组关联研究(GWAS)(分别为 7824 人;24925 人;和 115078 人),而与 MS 的遗传关联来自国际多发性硬化症遗传学联合会(14802 例病例和 26703 例对照)的一项大型 GWAS。主要分析采用乘法随机效应倒数方差加权法进行,同时还采用加权中位数、加权模式、MR-Egger 和 MR-PRESSO 进行了多种敏感性分析。共有 29 种代谢物具有与 MS 因果关联的提示性证据。遗传上仪器化的丝氨酸(OR=1.56,95%CI=1.25-1.95)、赖氨酸(OR=1.18,95%CI=1.01-1.38)、丙酮(OR=2.45,95%CI=1.02-5.90)和乙酰乙酸(OR=2.47,95%CI=1.14-5.34)水平与较高的 MS 风险相关。大极低密度脂蛋白中的总胆固醇和磷脂与较低的 MS 风险相关(OR=0.83,95%CI=0.69-1.00;OR=0.80,95%CI=0.68-0.95),但同一两种脂质在非常大的高密度脂蛋白中观察到与风险增加相关的关联(OR=1.20,95%CI=1.04-1.40;OR=1.13,95%CI=1.00-1.28)。我们的代谢组学全基因组孟德尔随机化研究确定了一系列循环代谢物,如丝氨酸、赖氨酸、丙酮、乙酰乙酸和脂质等,这些代谢物可能与 MS 有因果关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06dc/10237183/0f58c9378f23/nihms-1904124-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06dc/10237183/7b1acb96a789/nihms-1904124-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06dc/10237183/3cb74a710393/nihms-1904124-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06dc/10237183/0f58c9378f23/nihms-1904124-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06dc/10237183/7b1acb96a789/nihms-1904124-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06dc/10237183/3cb74a710393/nihms-1904124-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06dc/10237183/0f58c9378f23/nihms-1904124-f0003.jpg

相似文献

1
A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosis.代谢组学全基因组关联研究优先考虑多发性硬化症的潜在因果循环代谢物。
J Neuroimmunol. 2023 Jun 15;379:578105. doi: 10.1016/j.jneuroim.2023.578105. Epub 2023 May 11.
2
A metabolome-wide Mendelian randomization study prioritizes causal circulating metabolites for reproductive disorders including primary ovarian insufficiency, polycystic ovary syndrome, and abnormal spermatozoa.一项代谢组学全基因组关联研究优先考虑了与生殖障碍相关的循环代谢物的因果关系,包括原发性卵巢功能不全、多囊卵巢综合征和异常精子症。
J Ovarian Res. 2024 Aug 14;17(1):166. doi: 10.1186/s13048-024-01486-1.
3
Causal association of genetically determined circulating vitamin D metabolites and calcium with multiple sclerosis in participants of European descent.在欧洲血统参与者中,基因决定的循环维生素D代谢物和钙与多发性硬化症的因果关联。
Eur J Clin Nutr. 2023 Apr;77(4):481-489. doi: 10.1038/s41430-023-01260-4. Epub 2023 Jan 12.
4
Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis.孟德尔随机化研究更新了 25-羟维生素 D 水平对多发性硬化风险的影响。
J Transl Med. 2022 Jan 3;20(1):3. doi: 10.1186/s12967-021-03205-6.
5
Non-targeted metabolomics revealed novel links between serum metabolites and primary ovarian insufficiency: a Mendelian randomization study.非靶向代谢组学揭示了血清代谢物与原发性卵巢功能不全之间的新联系:一项孟德尔随机研究。
Front Endocrinol (Lausanne). 2024 Apr 26;15:1307944. doi: 10.3389/fendo.2024.1307944. eCollection 2024.
6
Circulating Interleukins and Risk of Multiple Sclerosis: A Mendelian Randomization Study.循环白细胞介素与多发性硬化症风险:一项孟德尔随机研究。
Front Immunol. 2021 Apr 15;12:647588. doi: 10.3389/fimmu.2021.647588. eCollection 2021.
7
Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study.探讨血浆脂质和他汀类药物干预对多发性硬化风险和严重程度的作用:一项孟德尔随机研究。
Neurology. 2023 Oct 24;101(17):e1729-e1740. doi: 10.1212/WNL.0000000000207777. Epub 2023 Sep 1.
8
Causal relationship between multiple sclerosis and primary Sjögren's syndrome: a two-sample mendelian randomization study.多发性硬化症与原发性干燥综合征之间的因果关系:两样本孟德尔随机化研究。
Metab Brain Dis. 2024 Aug;39(6):1109-1115. doi: 10.1007/s11011-024-01379-8. Epub 2024 Jul 17.
9
Genetically predicted telomere length and multiple sclerosis.基因预测的端粒长度与多发性硬化症
Mult Scler Relat Disord. 2022 Apr;60:103731. doi: 10.1016/j.msard.2022.103731. Epub 2022 Mar 7.
10
Causal effects of gut microbiota on multiple sclerosis: A two-sample Mendelian randomization study.肠道微生物群对多发性硬化症的因果影响:两样本孟德尔随机研究。
Brain Behav. 2024 Jun;14(6):e3593. doi: 10.1002/brb3.3593.

引用本文的文献

1
Inflammation-metabolite crosstalk in multiple sclerosis: A mediation Mendelian randomization study of plasma inflammatory proteins, iron, and serum/cerebrospinal fluid metabolites.多发性硬化症中的炎症-代谢物相互作用:血浆炎症蛋白、铁以及血清/脑脊液代谢物的中介孟德尔随机化研究
Sci Prog. 2025 Jul-Sep;108(3):368504251378619. doi: 10.1177/00368504251378619. Epub 2025 Sep 15.
2
Evaluating metabolome-wide causal effects on risk for psychiatric and neurodegenerative disorders.评估代谢组范围内对精神疾病和神经退行性疾病风险的因果效应。
BMC Med. 2025 Jun 2;23(1):326. doi: 10.1186/s12916-025-04129-4.
3
Genetic evidence for the liver-brain axis: lipid metabolism and neurodegenerative disease risk.

本文引用的文献

1
Exploring the Role of Plasma Lipids and Statin Interventions on Multiple Sclerosis Risk and Severity: A Mendelian Randomization Study.探讨血浆脂质和他汀类药物干预对多发性硬化风险和严重程度的作用:一项孟德尔随机研究。
Neurology. 2023 Oct 24;101(17):e1729-e1740. doi: 10.1212/WNL.0000000000207777. Epub 2023 Sep 1.
2
Amino Acid Levels as Potential Biomarkers of Multiple Sclerosis in Elderly Patients: Preliminary Report.氨基酸水平作为老年多发性硬化症潜在生物标志物的初步报告。
J Clin Neurol. 2022 Sep;18(5):529-534. doi: 10.3988/jcn.2022.18.5.529.
3
Lipid and Lipoprotein Metabolism.
肝脑轴的遗传学证据:脂质代谢与神经退行性疾病风险
Lipids Health Dis. 2025 Feb 8;24(1):41. doi: 10.1186/s12944-025-02455-3.
4
Mendelian randomization study of causal link from Cerebrospinal fluid metabolomics to neurodegenerative diseases.脑脊液代谢组学与神经退行性疾病因果关系的孟德尔随机化研究。
Neurogenetics. 2024 Dec 6;26(1):15. doi: 10.1007/s10048-024-00792-6.
5
Harnessing Artificial Intelligence in Multimodal Omics Data Integration: Paving the Path for the Next Frontier in Precision Medicine.利用人工智能进行多模态组学数据整合:为精准医学的下一个前沿铺平道路。
Annu Rev Biomed Data Sci. 2024 Aug;7(1):225-250. doi: 10.1146/annurev-biodatasci-102523-103801. Epub 2024 Jul 24.
6
Identifying serum metabolite biomarkers for autoimmune diseases: a two-sample mendelian randomization and meta-analysis.鉴定自身免疫性疾病的血清代谢生物标志物:两样本孟德尔随机化和荟萃分析。
Front Immunol. 2024 Apr 15;15:1300457. doi: 10.3389/fimmu.2024.1300457. eCollection 2024.
脂类和脂蛋白代谢。
Endocrinol Metab Clin North Am. 2022 Sep;51(3):437-458. doi: 10.1016/j.ecl.2022.02.008. Epub 2022 Jul 4.
4
Role of Ketogenic Diets in Multiple Sclerosis and Related Animal Models: An Updated Review.生酮饮食在多发性硬化症及相关动物模型中的作用:最新综述。
Adv Nutr. 2022 Oct 2;13(5):2002-2014. doi: 10.1093/advances/nmac065.
5
The role of cholesterol metabolism in multiple sclerosis: From molecular pathophysiology to radiological and clinical disease activity.胆固醇代谢在多发性硬化中的作用:从分子病理生理学到影像学和临床疾病活动。
Autoimmun Rev. 2022 Jun;21(6):103088. doi: 10.1016/j.autrev.2022.103088. Epub 2022 Apr 6.
6
Body Mass Index, Interleukin-6 Signaling and Multiple Sclerosis: A Mendelian Randomization Study.体重指数、白细胞介素-6 信号与多发性硬化症:一项孟德尔随机化研究。
Front Immunol. 2022 Mar 21;13:834644. doi: 10.3389/fimmu.2022.834644. eCollection 2022.
7
Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.通过药物靶点孟德尔随机化来描述脂质调节治疗的代谢组学特征。
PLoS Biol. 2022 Feb 25;20(2):e3001547. doi: 10.1371/journal.pbio.3001547. eCollection 2022 Feb.
8
Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approach.用于多发性硬化症临床复发的客观生物标志物:一种代谢组学方法。
Brain Commun. 2021 Oct 12;3(4):fcab240. doi: 10.1093/braincomms/fcab240. eCollection 2021.
9
Childhood obesity and multiple sclerosis: A Mendelian randomization study.儿童肥胖与多发性硬化症:一项孟德尔随机化研究。
Mult Scler. 2021 Dec;27(14):2150-2158. doi: 10.1177/13524585211001781. Epub 2021 Mar 22.
10
The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: A Mendelian randomization mediation analysis.肥胖、维生素 D、瘦素和脂联素对多发性硬化症风险的相对贡献:一项孟德尔随机化中介分析。
Mult Scler. 2021 Nov;27(13):1994-2000. doi: 10.1177/1352458521995484. Epub 2021 Feb 19.